Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ontaneda

Showing results (111-120 of 193) with videos related to

Pageof 20
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2024
The onset presentation of multiple sclerosis differs in Hispanic/Latinx Americans compared with non-Hispanic White AmericansFarren Bs Briggs, Devon S Conway, Carrie M Hersh, et al.
Neurology|November 14, 2022
MRI Features of Anti-Ma1/Ma2 Paraneoplastic Neurologic SyndromeAmy C Kunchok, Daniel Ontaneda, Jonathan Lee, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|October 1, 2022
Gadolinium-based contrast agent exposures and physical and cognitive disability in multiple sclerosisKunio Nakamura, Marisa P McGinley, Stephen E Jones, et al.
Journal of Personalized Medicine|January 21, 2022
Recommendations for the Diagnosis and Treatment of Multiple Sclerosis RelapsesCristina Ramo-Tello, Yolanda Blanco, Luis Brieva, et al.
Multiple Sclerosis and Related Disorders|December 10, 2020
Comorbidity effect on processing speed test and MRI measures in multiple sclerosis patientsJustin R Abbatemarco, Daniel Ontaneda, Kunio Nakamura, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 8, 2019
Tuberculosis screening in multiple sclerosis: effect of disease-modifying therapies and lymphopenia on the prevalence of indeterminate TB screening results in the clinical settingLaura E Baldassari, Jenny Feng, Gabrielle Macaron, et al.
Neurology|January 2, 2020
Palatal myoclonus, abnormal eye movements, and olivary hypertrophy in GAD65-related disorderGabrielle Macaron, Mary A Willis, Daniel Ontaneda, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|October 28, 2024
A middle-aged man with patchy sensory deficits in the face and all extremities - Introducing an unusual phenotypeShervin Badihian, Heidi Mueller, Vijaya R Dasari, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 18, 2024
Multiple sclerosis subgroups: Data-driven clusters based on patient-reported outcomes and a large clinical sampleAlessandro S De Nadai, Ryan J Zamora, Alyse Finch, et al.
Neurology. Clinical Practice|June 7, 2024
Comparing Cognitive Profiles in Older Adults With Multiple Sclerosis and Alzheimer Disease: More Similarities Than DifferencesLaura M Hancock, Rachel Galioto, Tasha Rhoads, et al.
Pageof 20

Showing results (111-120 of 193) with videos related to

Sort By:
Pageof 20
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2024
The onset presentation of multiple sclerosis differs in Hispanic/Latinx Americans compared with non-Hispanic White AmericansFarren Bs Briggs, Devon S Conway, Carrie M Hersh, et al.
Neurology|November 14, 2022
MRI Features of Anti-Ma1/Ma2 Paraneoplastic Neurologic SyndromeAmy C Kunchok, Daniel Ontaneda, Jonathan Lee, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|October 1, 2022
Gadolinium-based contrast agent exposures and physical and cognitive disability in multiple sclerosisKunio Nakamura, Marisa P McGinley, Stephen E Jones, et al.
Journal of Personalized Medicine|January 21, 2022
Recommendations for the Diagnosis and Treatment of Multiple Sclerosis RelapsesCristina Ramo-Tello, Yolanda Blanco, Luis Brieva, et al.
Multiple Sclerosis and Related Disorders|December 10, 2020
Comorbidity effect on processing speed test and MRI measures in multiple sclerosis patientsJustin R Abbatemarco, Daniel Ontaneda, Kunio Nakamura, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 8, 2019
Tuberculosis screening in multiple sclerosis: effect of disease-modifying therapies and lymphopenia on the prevalence of indeterminate TB screening results in the clinical settingLaura E Baldassari, Jenny Feng, Gabrielle Macaron, et al.
Neurology|January 2, 2020
Palatal myoclonus, abnormal eye movements, and olivary hypertrophy in GAD65-related disorderGabrielle Macaron, Mary A Willis, Daniel Ontaneda, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|October 28, 2024
A middle-aged man with patchy sensory deficits in the face and all extremities - Introducing an unusual phenotypeShervin Badihian, Heidi Mueller, Vijaya R Dasari, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 18, 2024
Multiple sclerosis subgroups: Data-driven clusters based on patient-reported outcomes and a large clinical sampleAlessandro S De Nadai, Ryan J Zamora, Alyse Finch, et al.
Neurology. Clinical Practice|June 7, 2024
Comparing Cognitive Profiles in Older Adults With Multiple Sclerosis and Alzheimer Disease: More Similarities Than DifferencesLaura M Hancock, Rachel Galioto, Tasha Rhoads, et al.
Pageof 20